Operating Income (Loss) in USD of HUMANIGEN, INC from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Humanigen, Inc quarterly/annual Operating Income (Loss) history and change rate from 2010 to Q1 2023.
  • Humanigen, Inc Operating Income (Loss) for the quarter ending 31 Mar 2023 was -$4.24M, a 79.4% increase year-over-year.
  • Humanigen, Inc Operating Income (Loss) for the twelve months ending 31 Mar 2023 was -$52M, a 72.5% increase year-over-year.
  • Humanigen, Inc annual Operating Income (Loss) for 2022 was -$68.3M, a 70.7% increase from 2021.
  • Humanigen, Inc annual Operating Income (Loss) for 2021 was -$233M, a 164% decline from 2020.
  • Humanigen, Inc annual Operating Income (Loss) for 2020 was -$88.2M, a 886% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

HUMANIGEN, INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$52M -$4.24M +$16.3M +79.4% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 -$68.3M $4.3M +$36.6M 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023
Q3 2022 -$105M -$22.7M +$43.3M +65.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 -$148M -$29.4M +$40.7M +58.1% 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 -$189M -$20.5M +$43.9M +68.1% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$233M -$32.3M -$50K -0.16% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$233M -$66M -$35.2M -115% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$197M -$70.1M -$47M -203% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$151M -$64.4M -$62.3M -3031% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 -$88.2M -$32.3M -$30.6M -1822% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 -$57.6M -$30.7M -$28.7M -1403% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$28.9M -$23.1M -$20.1M -675% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$8.76M -$2.06M +$181K +8.09% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$8.94M -$1.68M +$50K +2.89% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2021
Q3 2019 -$8.99M -$2.05M +$293K +12.5% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$9.29M -$2.98M -$371K -14.2% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$8.92M -$2.24M +$2.42M +51.9% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$11.3M -$1.73M +$986K +36.3% 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 -$12.3M -$2.34M +$3.46M +59.7% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019
Q2 2018 -$15.8M -$2.61M +$2.79M +51.7% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019
Q1 2018 -$18.6M -$4.65M +$465K +9.09% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q4 2017 -$19M -$2.72M +$2.14M +44% 01 Oct 2017 31 Dec 2017 10-K 26 Mar 2019
Q3 2017 -$21.2M -$5.8M -$1.61M -38.3% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 -$19.6M -$5.4M +$1.47M +21.5% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$21M -$5.12M -$2.21M -75.9% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 -$18.8M -$4.85M +$8.32M +63.2% 01 Oct 2016 31 Dec 2016 10-K 27 Mar 2018
Q3 2016 -$27.1M -$4.19M +$2.01M +32.4% 01 Jul 2016 30 Sep 2016 10-Q 17 Nov 2017
Q2 2016 -$29.2M -$6.87M -$1.24M -22% 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017
Q1 2016 -$27.9M -$2.91M +$6.43M +68.9% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017
Q4 2015 -$34.4M -$13.2M -$3.86M -41.4% 01 Oct 2015 31 Dec 2015 10-K 09 Mar 2017
Q3 2015 -$30.5M -$6.2M +$1.51M +19.5% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 -$32M -$5.63M +$3.9M +40.9% 01 Apr 2015 30 Jun 2015 10-Q 23 Sep 2016
Q1 2015 -$35.9M -$9.34M +$818K +8.05% 01 Jan 2015 31 Mar 2015 10-Q 23 Sep 2016
Q4 2014 -$36.7M -$9.32M +$613K +6.17% 01 Oct 2014 31 Dec 2014 10-K 16 Mar 2015
Q3 2014 -$37.3M -$7.71M +$3.38M +30.5% 01 Jul 2014 30 Sep 2014 10-Q 01 Sep 2016
Q2 2014 -$40.7M -$9.53M +$2.04M +17.6% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 -$42.7M -$10.2M -$1.84M -22.1% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$40.9M -$9.93M +$2M +16.8% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 -$42.9M -$11.1M -$2.8M -33.7% 01 Jul 2013 30 Sep 2013 10-K 16 Mar 2015
Q2 2013 -$40.1M -$11.6M -$9.46M -448% 01 Apr 2013 30 Jun 2013 10-K 16 Mar 2015
Q1 2013 -$30.7M -$8.32M -$7.18M -626% 01 Jan 2013 31 Mar 2013 10-K 16 Mar 2015
Q4 2012 -$23.5M -$11.9M 01 Oct 2012 31 Dec 2012 10-K 13 Mar 2014
Q3 2012 -$8.29M -$7.33M -761% 01 Jul 2012 30 Sep 2012 10-K 13 Mar 2014
Q2 2012 -$2.11M -$921K -77.3% 01 Apr 2012 30 Jun 2012 10-K 13 Mar 2014
Q1 2012 -$1.15M 01 Jan 2012 31 Mar 2012 10-K 13 Mar 2014
Q3 2011 -$963K 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 -$1.19M 01 Apr 2011 30 Jun 2011 10-Q/A 11 Oct 2012

HUMANIGEN, INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$68.3M +$164M +70.7% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 -$233M -$145M -164% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$88.2M -$79.3M -886% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
2019 -$8.94M +$2.39M +21.1% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2021
2018 -$11.3M +$7.7M +40.5% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
2017 -$19M -$206K -1.09% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2019
2016 -$18.8M +$15.5M +45.2% 01 Jan 2016 31 Dec 2016 10-K 27 Mar 2018
2015 -$34.4M +$2.37M +6.44% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2017
2014 -$36.7M +$4.19M +10.2% 01 Jan 2014 31 Dec 2014 10-K 01 Sep 2016
2013 -$40.9M -$17.4M -74.2% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 -$23.5M -$21.2M -936% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 -$2.27M +$3.86M +63% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014
2010 -$6.12M 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.